Inventor · disambiguated record
Nicolas Ortonne
Also filed as: ORTONNE NICOLAS
0 granted patents·4 pending applications·0 citations·filing 2007–2022
Files withINST NAT SANTE RECH MED4
Top patents by PatentIndex Score
4 records- 0150US2024175873A1Methods for the diagnosis and treatment of t cell-lymphomasINST NAT SANTE RECH MED·Filed 2022·Application pending·0 cites
- 0248US2018291102A1Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomasINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 0347US2010008932A1Use of soluble cd160 to suppress immunityINST NAT SANTE RECH MED·Filed 2007·Application pending·0 cites
- 0446US2016130346A1Kir3dl2 is a biomarker and a therapeutic target useful for respectively preventing and treating a subset of cutaneous and non-cutaneous peripheral t-cell lymphomasINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicolas Ortonne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →